100357-3 |
Naloxone |
PrThr |
TissCo |
Pt |
Ord |
Screen |
|
ACTIVE |
Naloxone [Presence] in Cord tissue by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
100357-3 |
|
Screen |
|
|
Both |
|
|
|
0 |
Naloxone TissCo Ql Scn |
|
|
|
N |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Narcan; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100358-1 |
Phentermine |
PrThr |
TissCo |
Pt |
Ord |
Screen |
|
ACTIVE |
Phentermine [Presence] in Cord tissue by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
100358-1 |
|
Screen |
|
|
Both |
|
|
|
0 |
Phentermine TissCo Ql Scn |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Ionamin; Ordinal; PH; Point in time; PR; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100359-9 |
Gliadin 33 mer peptide |
MCnc |
Stool |
Pt |
Qn |
IA |
|
ACTIVE |
Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHEM |
|
100359-9 |
|
IA |
|
|
Both |
|
|
|
0 |
Gliadin 33 mer Stl IA-mCnc |
|
|
|
N |
|
Bowel movement; Celiac disease; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; F98; Faecal; Faeces; Fecal; Feces; Gliadine; IAA; Level; Mass concentration; MEIA; Pept; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; SUDS |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
10036-2 |
S wave amplitude.lead AVR |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
S wave amplitude in lead AVR |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10036-2 |
|
EKG |
|
|
Observation |
|
|
|
0 |
S wave Amp L-AVR |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S' wave Amp L-AVR; S wave Amp L-AVR; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
100360-7 |
Brief Resilience Scale panel |
- |
^Patient |
Pt |
- |
BRS |
|
ACTIVE |
Brief Resilience Scale panel [BRS] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.MTLHLTH |
|
100360-7 |
|
BRS |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
Pan; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH |
2.73 |
2.73 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
100361-5 |
Quickly recover from bad events |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Quickly recover from bad events |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
100361-5 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100362-3 |
Difficulty making it through stressful events |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Difficulty making it through stressful events |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
100362-3 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100363-1 |
Easily recover from a stressful event |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Easily recover from a stressful event |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
100363-1 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100364-9 |
Difficulty recovering from bad events |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Difficulty recovering from bad events |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
100364-9 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100365-6 |
Easily recover from difficulties |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Easily recover from difficulties |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
100365-6 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100366-4 |
Lengthy recovery from setbacks |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Lengthy recovery from setbacks |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
100366-4 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100367-2 |
Total Score |
Score |
^Patient |
Pt |
Qn |
BRS |
|
ACTIVE |
Total Score BRS |
|
ADD |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
100367-2 |
|
BRS |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl |
2.73 |
2.73 |
|
|
|
|
|
|
|
{score} |
|
|
|
0 |
100368-0 |
Amino Acids Urea Cycle Panel |
- |
Ser/Plas |
Pt |
- |
LC/MS/MS |
|
ACTIVE |
Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
100368-0 |
|
LC/MS/MS |
|
|
Order |
|
|
|
0 |
AAUCD SerPl LC/MS/MS |
|
|
|
N |
|
AA; AAUCD; Acd; Acid; Amino acid; Amino acids.total; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.73 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
100369-8 |
Views^W Tl-201 IV |
Find |
Neck>Thyroid gland |
Pt |
Doc |
NM |
|
ACTIVE |
NM Thyroid gland Views W Tl-201 IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
100369-8 |
|
NM |
|
|
Both |
|
|
|
0 |
NM Thyroid Views W Tl-201 IV |
|
|
|
N |
|
201TI; Document; Films; Finding; Findings; Imaging; Point in time; Radiology; Random; Scan; Thallium 201; Thallous; Thy; T-I201; TL-201; View; VWS |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10037-0 |
S wave amplitude.lead I |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
S wave amplitude in lead I |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10037-0 |
|
EKG |
|
|
Observation |
|
|
|
0 |
S wave Amp L-I |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S' wave Amp L-I; S wave Amp L-I; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
100370-6 |
Orthopoxvirus DNA |
Prid |
XXX |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100370-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Orthopoxvirus DNA Spec NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Identity or presence; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Orthopox virus; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100371-4 |
Titin Ab |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Titin Ab [Units/volume] in Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
index value |
|
|
|
|
|
|
SERO |
|
100371-4 |
|
IA |
|
|
Both |
|
|
|
0 |
Titin Ab Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Myasthenia gravis; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; Thymoma |
2.73 |
2.73 |
|
|
|
|
|
|
|
{Index_val} |
|
|
|
0 |
100372-2 |
Abiraterone |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Abiraterone [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
100372-2 |
|
|
|
|
Both |
|
|
|
0 |
Abiraterone SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
100373-0 |
Eucheuma Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Eucheuma IgG Ab [Units/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
kIU/l |
|
|
|
|
|
|
ALLERGY |
|
100373-0 |
|
|
|
|
Both |
|
|
|
0 |
Agar- agar IgG Qn |
|
|
|
N |
|
ABS; Aby; Agar- agar; Agar- agar IgG; Agar-Agar; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
100374-8 |
Aloe vera Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Aloe vera IgG Ab [Units/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
kIU/l |
|
|
|
|
|
|
ALLERGY |
|
100374-8 |
|
|
|
|
Both |
|
|
|
0 |
Aloe vera IgG Qn |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
100375-5 |
Pimpinella anisum Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Anise IgG Ab [Units/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
kIU/l |
|
|
|
|
|
|
ALLERGY |
|
100375-5 |
|
|
|
|
Both |
|
|
|
0 |
Anise IgG Qn |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Anise; Aniseed; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f271; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf271; Serum; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
100376-3 |
Bambusa vulgaris Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Bambusa vulgaris IgG Ab [Units/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
kIU/l |
|
|
|
|
|
|
ALLERGY |
|
100376-3 |
|
|
|
|
Both |
|
|
|
0 |
Bambusa vulgaris IgG Qn |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
100377-1 |
Goat cheese Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Goat cheese IgG Ab [Units/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
kIU/l |
|
|
|
|
|
|
ALLERGY |
|
100377-1 |
|
|
|
|
Both |
|
|
|
0 |
Goat cheese IgG Qn |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; chevre; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
100378-9 |
Sheep cheese Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Sheep cheese IgG Ab [Units/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
kIU/l |
|
|
|
|
|
|
ALLERGY |
|
100378-9 |
|
|
|
|
Both |
|
|
|
0 |
Sheep cheese IgG Qn |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Feta; Immune globulin G; Immunoglobulin G; Ovine; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
100379-7 |
Allium ampeloprasum Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Leeks IgG Ab [Units/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
kIU/l |
|
|
|
|
|
|
ALLERGY |
|
100379-7 |
|
|
|
|
Both |
|
|
|
0 |
Leeks IgG Qn |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allium porrum; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Leek; Leeks; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |